Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2.
about
Beyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Theranostic applications of phage display to control leishmaniasis: selection of biomarkers for serodiagnostics, vaccination, and immunotherapyPhage display as a promising approach for vaccine developmentExpression of a 28-kilodalton glutathione S-transferase antigen of Schistosoma mansoni on the surface of filamentous phages and evaluation of its vaccine potential.Detection of HLA class II-dependent T helper antigen using antigen phage display.Phage displaying peptides mimic schistosoma antigenic epitopes selected by rat natural antibodies and protective immunity induced by their immunization in mice.Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes.Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.Phage display creates innovative applications to combat hepatitis B virusArchitectural insight into inovirus-associated vectors (IAVs) and development of IAV-based vaccines inducing humoral and cellular responses: implications in HIV-1 vaccinesIn vivo characteristics of targeted drug-carrying filamentous bacteriophage nanomedicinesBacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.Phage display peptide libraries in molecular allergology: from epitope mapping to mimotope-based immunotherapy.Glycoprotein G of herpes simplex virus 2 as a novel vaccine antigen for immunity to genital and neurological disease.Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.Oral Immunization of Rabbits with S. enterica Typhimurium Expressing Neisseria gonorrhoeae Filamentous Phage Φ6 Induces Bactericidal Antibodies Against N. gonorrhoeae.Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen.Phage displayed HBV core antigen with immunogenic activityPhage proteins are expressed on the surface of Neisseria gonorrhoeae and are potential vaccine candidates
P2860
Q26795483-4102F7CD-9E02-4138-97A3-9F43CD704462Q26796580-D858382A-D2D2-48E8-B642-55390DB1FBC0Q28074592-F0F6B07C-7AD2-4BB9-8A4C-F96F83DD2518Q30782735-BEFFD607-0977-4499-BDC4-EA3293D2B08FQ31037295-E693B2F4-5CF1-40BA-B587-6041F4FED70EQ33215338-21A904B0-B950-45B8-A49E-542085E061C9Q33520582-F238EA5B-7B23-447A-9E53-21939C2C2382Q33695321-7468FE05-A92F-4FAC-9FD4-98879AA3668DQ34137308-77E89972-3AE4-412B-91DE-4725FC8CF732Q34774808-22A88A0F-D69A-4C4B-8A63-CD382BDB48A4Q35763456-369ACFFC-40A3-4E26-88F0-1E9A58477A1BQ35963673-EA769CA5-328C-4FC8-A4BA-CC1B6642C243Q35987717-659560CC-1A0B-497A-B61F-EC7CC1552038Q36061055-A07B5564-F0DE-40DC-AD88-F8C991AC635EQ36155337-32BB3FB1-E5B5-4914-A0C0-B6A70E2E15BFQ36228216-F2D018D6-0ADE-4044-B63E-64922EF68268Q36650971-5A693850-8AC5-4876-A898-82BF5E11BEC9Q39430508-2F3B28C1-6D94-4D69-85D1-07CB3096276FQ56892550-853FB202-E075-42AB-A40C-4953AF5C0284Q58715493-57D29F7E-B981-4236-A4D0-D5425B7922B8
P2860
Immunisation with phage displaying peptides representing single epitopes of the glycoprotein G can give rise to partial protective immunity to HSV-2.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Immunisation with phage displa ...... protective immunity to HSV-2.
@ast
Immunisation with phage displa ...... protective immunity to HSV-2.
@en
type
label
Immunisation with phage displa ...... protective immunity to HSV-2.
@ast
Immunisation with phage displa ...... protective immunity to HSV-2.
@en
prefLabel
Immunisation with phage displa ...... protective immunity to HSV-2.
@ast
Immunisation with phage displa ...... protective immunity to HSV-2.
@en
P2093
P356
P1433
P1476
Immunisation with phage displa ...... l protective immunity to HSV-2
@en
P2093
P356
10.1006/VIRO.2000.0185
P407
P577
2000-03-01T00:00:00Z